QRG Capital Management’s Exact Sciences EXAS Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
Sell
-14,601
Closed -$1.48M 1161
2025
Q4
$1.48M Buy
14,601
+2,888
+25% +$232K 0.02% 467
2025
Q3
$641K Sell
11,713
-39,745
-77% -$1.99M 0.01% 640
2025
Q2
$2.73M Buy
51,458
+7,869
+18% +$400K 0.02% 418
2025
Q1
$1.89M Buy
43,589
+1,128
+3% +$57.1K 0.02% 463
2024
Q4
$2.39M Buy
42,461
+84
+0.2% +$5.23K 0.02% 430
2024
Q3
$2.89M Buy
42,377
+5,134
+14% +$290K 0.03% 389
2024
Q2
$1.57M Buy
37,243
+2,070
+6% +$114K 0.02% 463
2024
Q1
$2.43M Buy
35,173
+2,952
+9% +$187K 0.03% 380
2023
Q4
$2.38M Sell
32,221
-492
-2% -$32.2K 0.04% 365
2023
Q3
$2.23M Buy
+32,713
New +$2.78M 0.04% 356

Other funds holding EXAS

QRG Capital Management's EXAS Position: Q1 2026 in Review

QRG Capital Management sold out of Exact Sciences (EXAS) in Q1 2026, closing a stake of 14,601 shares — an estimated $1.48M sold.

QRG Capital Management first reported a position in EXAS in Q3 2023 and held it in 10 quarters. The position peaked at $2.89M in Q3 2024. 7 funds tracked by Wall St. Rank hold EXAS as of Q1 2026.

  • QRG Capital Management reported no remaining Exact Sciences position as of Q1 2026 after selling out during the quarter.
  • QRG Capital Management sold 14,601 Exact Sciences shares in Q1 2026, an estimated $1.48M.
  • QRG Capital Management first reported a position in Exact Sciences in Q3 2023 and held it in 10 quarters.
  • QRG Capital Management's Exact Sciences position peaked at $2.89M in Q3 2024.
  • 7 funds tracked by Wall St. Rank held Exact Sciences as of Q1 2026.

Based on QRG Capital Management's 13F filing for Q1 2026, filed 27 Apr 2026.